Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1086.0000 2.10 (0.19%)
NSE Oct 01, 2025 15:31 PM
Volume: 1.0M
 

1086.00
0.19%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1117.4
More from Aurobindo Pharma Ltd.
Recommended